Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 10 de 10
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
EMBO Rep ; 23(7): e53600, 2022 07 05.
Article de Anglais | MEDLINE | ID: mdl-35607830

RÉSUMÉ

The dengue virus nonstructural protein 1 (NS1) is a secreted virulence factor that modulates complement, activates immune cells and alters endothelial barriers. The molecular basis of these events remains incompletely understood. Here we describe a functional high affinity complex formed between NS1 and human high-density lipoproteins (HDL). Collapse of the soluble NS1 hexamer upon binding to the lipoprotein particle leads to the anchoring of amphipathic NS1 dimeric subunits into the HDL outer layer. The stable complex can be visualized by electron microscopy as a spherical HDL with rod-shaped NS1 dimers protruding from the surface. We further show that the assembly of NS1-HDL complexes triggers the production of pro-inflammatory cytokines in human primary macrophages while NS1 or HDL alone do not. Finally, we detect NS1 in complex with HDL and low-density lipoprotein (LDL) particles in the plasma of hospitalized dengue patients and observe NS1-apolipoprotein E-positive complexes accumulating overtime. The functional reprogramming of endogenous lipoprotein particles by NS1 as a means to exacerbate systemic inflammation during viral infection provides a new paradigm in dengue pathogenesis.


Sujet(s)
Virus de la dengue , Dengue , Dengue/métabolisme , Virus de la dengue/physiologie , Humains , Lipoprotéines HDL/métabolisme , Phagocytose , Protéines virales non structurales/métabolisme
2.
Nat Neurosci ; 24(1): 34-46, 2021 01.
Article de Anglais | MEDLINE | ID: mdl-33288908

RÉSUMÉ

Autonomous regulation of the intestine requires the combined activity of functionally distinct neurons of the enteric nervous system (ENS). However, the variety of enteric neuron types and how they emerge during development remain largely unknown. Here, we define a molecular taxonomy of 12 enteric neuron classes within the myenteric plexus of the mouse small intestine using single-cell RNA sequencing. We present cell-cell communication features and histochemical markers for motor neurons, sensory neurons and interneurons, together with transgenic tools for class-specific targeting. Transcriptome analysis of the embryonic ENS uncovers a novel principle of neuronal diversification, where two neuron classes arise through a binary neurogenic branching and all other identities emerge through subsequent postmitotic differentiation. We identify generic and class-specific transcriptional regulators and functionally connect Pbx3 to a postmitotic fate transition. Our results offer a conceptual and molecular resource for dissecting ENS circuits and predicting key regulators for directed differentiation of distinct enteric neuron classes.


Sujet(s)
Plexus myentérique/composition chimique , Neurones/composition chimique , ARN/composition chimique , ARN/génétique , Analyse sur cellule unique , Animaux , Communication cellulaire , Système nerveux entérique/physiologie , Protéines à homéodomaine/génétique , Interneurones/physiologie , Souris , Souris de lignée C57BL , Motoneurones/physiologie , Plexus myentérique/cytologie , Neurones/classification , Neurones/ultrastructure , Protéines proto-oncogènes/génétique , Cellules réceptrices sensorielles/physiologie , Analyse de séquence d'ARN , Transcriptome
3.
J Virol ; 94(14)2020 07 01.
Article de Anglais | MEDLINE | ID: mdl-32350074

RÉSUMÉ

HIV-1 successfully establishes long-term infection in its target cells despite viral cytotoxic effects. We have recently shown that cell metabolism is an important factor driving CD4+ T cell susceptibility to HIV-1 and the survival of infected cells. We show here that expression of antiapoptotic clone 11 (AAC-11), an antiapoptotic factor upregulated in many cancers, increased with progressive CD4+ T cell memory differentiation in association with the expression of cell cycle, activation, and metabolism genes and was correlated with susceptibility to HIV-1 infection. Synthetic peptides based on the LZ domain sequence of AAC-11, responsible for its interaction with molecular partners, were previously shown to be cytotoxic to cancer cells. Here, we observed that these peptides also blocked HIV-1 infection by inducing the death of HIV-1-susceptible primary CD4+ T cells across all T cell subsets. The peptides targeted metabolically active cells and had the greatest effect on effector and transitional CD4+ T cell memory subsets. Our results suggest that the AAC-11 survival pathway is potentially involved in the survival of HIV-1-infectible cells and provide proof of principle that some cellular characteristics can be targeted to eliminate the cells offering the best conditions to sustain HIV-1 replication.IMPORTANCE Although antiretroviral treatment efficiently blocks HIV multiplication, it cannot eliminate cells already carrying integrated proviruses. In the search for an HIV cure, the identification of new potential targets to selectively eliminate infected cells is of the outmost importance. We show here that peptides derived from antiapoptotic clone 11 (AAC-11), whose expression levels correlated with susceptibility to HIV-1 infection of CD4+ T cells, induced cytotoxicity in CD4+ T cells showing the highest levels of activation and metabolic activity, conditions known to favor HIV-1 infection. Accordingly, CD4+ T cells that survived the cytotoxic action of the AAC-11 peptides were resistant to HIV-1 replication. Our results identify a new potential molecular pathway to target HIV-1 infection.


Sujet(s)
Protéines régulatrices de l'apoptose/pharmacologie , Lymphocytes T CD4+/immunologie , Infections à VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Mémoire immunologique/effets des médicaments et des substances chimiques , Protéines nucléaires/pharmacologie , Peptides/pharmacologie , Réplication virale/effets des médicaments et des substances chimiques , Protéines régulatrices de l'apoptose/composition chimique , Lymphocytes T CD4+/anatomopathologie , Lymphocytes T CD4+/virologie , Prédisposition aux maladies , Infections à VIH/traitement médicamenteux , Infections à VIH/anatomopathologie , Humains , Protéines nucléaires/composition chimique , Peptides/composition chimique , Domaines protéiques , Réplication virale/immunologie
4.
Cell Microbiol ; 22(5): e13166, 2020 05.
Article de Anglais | MEDLINE | ID: mdl-31957253

RÉSUMÉ

Strategies employed by pathogenic enteric bacteria, such as Shigella, to subvert the host adaptive immunity are not well defined. Impairment of T lymphocyte chemotaxis by blockage of polarised edge formation has been reported upon Shigella infection. However, the functional impact of Shigella on T lymphocytes remains to be determined. Here, we show that Shigella modulates CD4+ T cell F-actin dynamics and increases cell cortical stiffness. The scanning ability of T lymphocytes when encountering antigen-presenting cells (APC) is subsequently impaired resulting in decreased cell-cell contacts (or conjugates) between the two cell types, as compared with non-infected T cells. In addition, the few conjugates established between the invaded T cells and APCs display no polarised delivery and accumulation of the T cell receptor to the contact zone characterising canonical immunological synapses. This is most likely due to the targeting of intracellular vesicular trafficking by the bacterial type III secretion system (T3SS) effectors IpaJ and VirA. The collective impact of these cellular reshapings by Shigella eventually results in T cell activation dampening. Altogether, these results highlight the combined action of T3SS effectors leading to T cell defects upon Shigella infection.


Sujet(s)
Cytosquelette d'actine/métabolisme , Immunité acquise , Dysenterie bacillaire/immunologie , Transport des protéines/physiologie , Récepteurs aux antigènes des cellules T/métabolisme , Shigella/métabolisme , Actines , Lignée cellulaire , Appareil de Golgi , Humains , Synapses immunologiques , Shigella/génétique , Lymphocytes T/immunologie , Systèmes de sécrétion de type III/métabolisme
5.
Cell Metab ; 29(3): 611-626.e5, 2019 03 05.
Article de Anglais | MEDLINE | ID: mdl-30581119

RÉSUMÉ

HIV persists in long-lived infected cells that are not affected by antiretroviral treatment. These HIV reservoirs are mainly located in CD4+ T cells, but their distribution is variable in the different subsets. Susceptibility to HIV-1 increases with CD4+ T cell differentiation. We evaluated whether the metabolic programming that supports the differentiation and function of CD4+ T cells affected their susceptibility to HIV-1. We found that differences in HIV-1 susceptibility between naive and more differentiated subsets were associated with the metabolic activity of the cells. Indeed, HIV-1 selectively infected CD4+ T cells with high oxidative phosphorylation and glycolysis, independent of their activation phenotype. Moreover, partial inhibition of glycolysis (1) impaired HIV-1 infection in vitro in all CD4+ T cell subsets, (2) decreased the viability of preinfected cells, and (3) precluded HIV-1 amplification in cells from HIV-infected individuals. Our results elucidate the link between cell metabolism and HIV-1 infection and identify a vulnerability in tackling HIV reservoirs.


Sujet(s)
Lymphocytes T CD4+/métabolisme , Infections à VIH/métabolisme , Sous-populations de lymphocytes T/métabolisme , Lymphocytes T CD4+/anatomopathologie , Différenciation cellulaire , Cellules cultivées , Glycolyse/immunologie , Infections à VIH/anatomopathologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Humains , Activation des lymphocytes , Phosphorylation oxydative , Sous-populations de lymphocytes T/anatomopathologie
6.
Adv Exp Med Biol ; 1075: 213-239, 2018.
Article de Anglais | MEDLINE | ID: mdl-30030795

RÉSUMÉ

The era of antiretroviral therapy has made HIV-1 infection a manageable chronic disease for those with access to treatment. Despite treatment, virus persists in tissue reservoirs seeded with long-lived infected cells that are resistant to cell death and immune recognition. Which cells contribute to this reservoir and which factors determine their persistence are central questions that need to be answered to achieve viral eradication. In this chapter, we describe how cell susceptibility to infection, resistance to cell death, and immune-mediated killing as well as natural cell life span and turnover potential are central components that allow persistence of different lymphoid and myeloid cell subsets that were recently identified as key players in harboring latent and actively replicating virus. The relative contribution of these subsets to persistence of viral reservoir is described, and the open questions are highlighted.


Sujet(s)
Agents antiVIH/usage thérapeutique , Infections à VIH/traitement médicamenteux , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , Virémie/traitement médicamenteux , Agents antiVIH/pharmacologie , Apoptose , Résistance virale aux médicaments , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/classification , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/physiologie , Humains , Échappement immunitaire , Cellules myéloïdes/virologie , Récepteur VIH/métabolisme , Sous-populations de lymphocytes T/virologie , Charge virale , Latence virale , Réplication virale
7.
Mol Syst Biol ; 14(3): e7881, 2018 03 26.
Article de Anglais | MEDLINE | ID: mdl-29581149

RÉSUMÉ

Defining correlates of immunity by comprehensively interrogating the extensive biological diversity in naturally or experimentally protected subjects may provide insights critical for guiding the development of effective vaccines and antibody-based therapies. We report advances in a humoral immunoprofiling approach and its application to elucidate hallmarks of effective HIV-1 viral control. Systematic serological analysis for a cohort of HIV-infected subjects with varying viral control was conducted using both a high-resolution, high-throughput biophysical antibody profiling approach, providing unbiased dissection of the humoral response, along with functional antibody assays, characterizing antibody-directed effector functions such as complement fixation and phagocytosis that are central to protective immunity. Profiles of subjects with varying viral control were computationally analyzed and modeled in order to deconvolute relationships among IgG Fab properties, Fc characteristics, and effector functions and to identify humoral correlates of potent antiviral antibody-directed effector activity and effective viral suppression. The resulting models reveal multifaceted and coordinated contributions of polyclonal antibodies to diverse antiviral responses, and suggest key biophysical features predictive of viral control.


Sujet(s)
Anticorps antiviraux/analyse , Infections à VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , Tests de fixation du complément , Biologie informatique/méthodes , Humains , Immunité humorale , Phagocytose
8.
PLoS Pathog ; 12(1): e1005315, 2016 Jan.
Article de Anglais | MEDLINE | ID: mdl-26745376

RÉSUMÉ

Elite controllers (ECs) represent a unique model of a functional cure for HIV-1 infection as these individuals develop HIV-specific immunity able to persistently suppress viremia. Because accumulating evidence suggests that HIV controllers generate antibodies with enhanced capacity to drive antibody-dependent cellular cytotoxicity (ADCC) that may contribute to viral containment, we profiled an array of extra-neutralizing antibody effector functions across HIV-infected populations with varying degrees of viral control to define the characteristics of antibodies associated with spontaneous control. While neither the overall magnitude of antibody titer nor individual effector functions were increased in ECs, a more functionally coordinated innate immune-recruiting response was observed. Specifically, ECs demonstrated polyfunctional humoral immune responses able to coordinately recruit ADCC, other NK functions, monocyte and neutrophil phagocytosis, and complement. This functionally coordinated response was associated with qualitatively superior IgG3/IgG1 responses, whereas HIV-specific IgG2/IgG4 responses, prevalent among viremic subjects, were associated with poorer overall antibody activity. Rather than linking viral control to any single activity, this study highlights the critical nature of functionally coordinated antibodies in HIV control and associates this polyfunctionality with preferential induction of potent antibody subclasses, supporting coordinated antibody activity as a goal in strategies directed at an HIV-1 functional cure.


Sujet(s)
Anticorps neutralisants/immunologie , Anticorps anti-VIH/immunologie , Infections à VIH/immunologie , Immunoglobuline G/immunologie , Cytotoxicité à médiation cellulaire dépendante des anticorps/immunologie , Humains , Cellules tueuses naturelles/immunologie , Activation des lymphocytes/immunologie
9.
Clin Vaccine Immunol ; 21(10): 1437-42, 2014 Oct.
Article de Anglais | MEDLINE | ID: mdl-25121777

RÉSUMÉ

Individuals with human immunodeficiency virus (HIV) infection have increased susceptibility to invasive disease caused by Salmonella enterica serovar Typhimurium. Studies from Africa have suggested that this susceptibility is related in part to the development of a high level of lipopolysaccharide (LPS)-specific IgG that is able to inhibit the killing of S. Typhimurium by bactericidal antibodies in healthy individuals. To explore this issue further, we examined the bactericidal activity against S. Typhimurium using serum and plasma samples from healthy controls and various clinical subgroups of HIV-infected adults in the United States. We found that the bactericidal activity in the samples from HIV-positive elite controllers was comparable to that from healthy individuals, whereas it was significantly reduced in HIV-positive viremic controllers and untreated chronic progressors. As demonstrated previously for healthy controls, the bactericidal activity of the plasma from the elite controllers was inhibited by preincubation with S. Typhimurium LPS, suggesting that it was mediated by anti-LPS antibodies. S. Typhimurium LPS-specific IgG was significantly reduced in all subgroups of HIV-infected individuals. Interestingly, and in contrast to the healthy controls, plasma from all HIV-positive subgroups inhibited in vitro killing of S. Typhimurium by plasma from a healthy individual. Our results, together with the findings from Africa, suggest that multiple mechanisms may be involved in the HIV-induced dysregulation of humoral immunity to S. Typhimurium.


Sujet(s)
Anticorps antibactériens/sang , Activité bactéricide du sang , Infections à VIH/immunologie , Salmonelloses/immunologie , Salmonella typhimurium/immunologie , Adulte , Afrique , Humains , Immunoglobuline G/sang , Lipopolysaccharides/immunologie , Plasma sanguin/immunologie , États-Unis
10.
Blood ; 119(21): 4919-27, 2012 May 24.
Article de Anglais | MEDLINE | ID: mdl-22490680

RÉSUMÉ

Dendritic cell (DC) homeostasis in peripheral tissues reflect a balance between DC generation, migration, and death. The current model of DC ontogeny indicates that pre-cDCs are committed to become terminal conventional DCs (cDCs). Here, we report the unexpected finding that proliferating immunostimulatory CD11c(+) MHC class II(+) cDCs derived from pre-cDCs can lose their DC identity and generate progeny that exhibit morphologic, phenotypic, and functional characteristics of regulatory macrophages. DC-derived-macrophages (DC-d-Ms) potently suppress T-cell responses through the production of immunosuppressive molecules including nitric oxide, arginase, and IL-10. Relative deficiency of granulocyte-macrophage colony stimulating factor (GM-CSF) provided a permissive signal for DC-d-M generation. Using a transgenic mouse model that allows tracking of CD11c(+) cells in vivo, we found that DC-d-M development occurs commonly in cancer, but not in lymphoid or nonlymphoid tissues under steady-state conditions. We propose that this developmental pathway serves as an alternative mechanism of regulating DC homeostasis during inflammatory processes.


Sujet(s)
Différenciation cellulaire , Cellules dendritiques/immunologie , Cellules dendritiques/physiologie , Macrophages/cytologie , Macrophages/physiologie , Animaux , Animaux nouveau-nés , Antigènes CD11/génétique , Antigènes CD11/métabolisme , Carcinome pulmonaire de Lewis/immunologie , Carcinome pulmonaire de Lewis/anatomopathologie , Différenciation cellulaire/génétique , Différenciation cellulaire/immunologie , Cellules cultivées , Cellules dendritiques/métabolisme , Macrophages/immunologie , Macrophages/métabolisme , Mâle , Mélanome expérimental/immunologie , Mélanome expérimental/métabolisme , Mélanome expérimental/anatomopathologie , Souris , Souris congéniques , Souris de lignée BALB C , Souris de lignée C57BL , Souris transgéniques
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...